Finance

Lists
PRTC:LON
Puretech Health PLC
GBX 114.40
-1.38%
(-1.60) 1D
Sep 25, 4:35:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for PRTC...
Open
GBX 116.20
High
GBX 117.00
Low
GBX 114.37
Mkt. cap
280.95M
Avg. vol.
753.99K
Volume
651.61K
P/E ratio
1,395.12
52-wk high
GBX 143.60
52-wk low
GBX 107.40
EPS
GBX 0.00
Shares outstanding
245.18M
No. of employees
90
Open
GBX 116.20
High
GBX 117.00
Low
GBX 114.37
Mkt. cap
280.95M
Avg. vol.
753.99K
Volume
651.61K
P/E ratio
1,395.12
52-wk high
GBX 143.60
52-wk low
GBX 107.40
EPS
GBX 0.00
Shares outstanding
245.18M
No. of employees
90
Profile
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange. Wikipedia
About Puretech Health PLC
CEO-
Employees90
Founded2005
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitepuretechhealth.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
925.50K
925.50K
1.40M
1.40M
Cost of goods sold
12.45M
12.45M
15.78M
15.78M
Cost of revenue
12.45M
12.45M
15.78M
15.78M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.44M
12.44M
10.87M
10.87M
Operating expense
12.44M
12.44M
10.87M
10.87M
Total operating expenses
24.89M
24.89M
26.64M
26.64M
Operating income
-23.97M
-23.97M
-25.24M
-25.24M
Other non operating income
459.00K
459.00K
207.00K
207.00K
EBT including unusual items
-21.93M
-21.93M
-33.53M
-33.53M
EBT excluding unusual items
-22.45M
-22.45M
-51.43M
-51.43M
Income tax expense
461.50K
461.50K
-882.50K
-882.50K
Effective tax rate
-2.10%
-2.10%
2.63%
2.63%
Other operating expenses
-
-
-
-
Net income
-22.30M
-22.30M
-32.57M
-32.57M
Net profit margin
-2,409.78%
-2,409.78%
-2,319.59%
-2,319.59%
Earnings per share
-
-
-
-
Interest and investment income
3.54M
3.54M
2.99M
2.99M
Interest expense
-473.00K
-473.00K
-22.42M
-22.42M
Net interest expenses
3.06M
3.06M
-19.43M
-19.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.12M
-23.12M
-24.70M
-24.84M
Gain or loss from assets sale
-47.00K
-47.00K
500.00
500.00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps